Celldex Therapeutics, Inc. · NASDAQ:CLDX

FMR LLC reported a 5.60% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 6, 2026

FMR LLC reported a 5.60% stake in Celldex Therapeutics, Inc., 3,749,048 shares, as a passive investor on Mar 31, 2026. Filed May 6, 2026 (Schedule 13G/A).

Stake
5.60%
Shares
3,749,048
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC5.60%3,749,048
Abigail P. Johnson5.60%3,749,048

Source

View original at SEC

Related